Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Stapuldencel T - SOTIO

Next Previous
X
Search
Drug Profile

Stapuldencel T - SOTIO

Alternative Names: DCVAC-PCa; DCVAC/PCa; Dendritic cell vaccine/Prostate cancer - Sotio

Latest Information Update: 17 Sep 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SOTIO
  • Class Cancer vaccines; Cell therapies; Dendritic cell vaccines; Immunotherapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Prostate cancer

Most Recent Events

  • 25 Jan 2021 SOTIO terminates the phase I/II SP015 trial in Prostate cancer (Late-stage disease, Combination therapy, Metastatic disease, Second-line therapy or greater, Hormone refractory) in Czech Republic (Intratumoural) (owing to insufficient patient accrual) (NCT03514836) (EudraCT2015-004314-15)
  • 28 Jan 2020 Sotio completes the phase III VIABLE trial for Prostate cancer (Combination therapy, First-line therapy, Hormone refractory, Metastatic disease) in USA, United Kingdom, Czech Republic, Austria, Belarus, Denmark, France, Latvia, Lithuania, Poland, Sweden, Germany, Belgium, Serbia, Italy, the Netherlands, Hungary, Portugal, Spain, Bulgaria, Slovakia, Turkey and Croatia (NCT02111577)
  • 30 Oct 2018 Sotio completes a phase II trial in Prostate cancer (Late-stage disease) in Czech Republic (SC) (EudraCT 2011-004967-65) (NCT02107430)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top